The charts on this page feature a breakdown of the total annual pay for the top executives at CVS HEALTH CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CVS HEALTH CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CVS HEALTH CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Larry J. Merlo
President and Chief Executive Officer
Total Cash $12,255,000 Equity $23,624,966 Other $571,783 Total Compensation $36,451,749
Jonathan C. Roberts
Executive Vice President and Chief Operating Officer
Total Cash $7,327,000 Equity $7,499,967 Other $221,413 Total Compensation $15,048,380
Thomas M. Moriarty
Executive Vice President, Chief Policy and Chief Policy and and General Counsel
Total Cash $5,671,833 Equity $17,374,956 Other $108,145 Total Compensation $23,154,934
Eva C. Boratto
Executive Vice President and Chief Financial Officer
Total Cash $4,438,000 Equity $4,999,980 Other $126,243 Total Compensation $9,564,223
Derica W. Rice
Executive Vice President and President - CVS Caremark
Total Cash $4,483,111 Equity $5,999,966 Other $143,142 Total Compensation $10,626,219
For its 2019 fiscal year, CVS HEALTH CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Larry J. Merlo CEO Pay $36,466,470 Median Employee Pay $46,140 CEO Pay Ratio 790:1
For its 2019 fiscal year, CVS HEALTH CORP, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Alecia A. DeCoudreaux Total Cash $310,973
Anne M. Finucane Total Cash $310,000
C. David Brown, II Total Cash $332,210
David W. Dorman Total Cash $585,000
Edward J. Ludwig Total Cash $339,740
Fernando Aguirre Total Cash $310,000
Jean-Pierre Millon Total Cash $312,043
Mark T. Bertolini Total Cash $310,000
Mary L. Schapiro Total Cash $310,000
Nancy-Ann M. DeParle Total Cash $325,000
Richard J. Swift Total Cash $337,043
Richard M. Bracken Total Cash $325,851
Roger N. Farah Total Cash $310,000
Tony L. White Total Cash $312,043
William C. Weldon Total Cash $310,000

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.